PMC:7441788 / 5954-6137 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T19","span":{"begin":88,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T51","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"T52","span":{"begin":131,"end":139},"obj":"Disease"}],"attributes":[{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":31,"end":39},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T60","span":{"begin":81,"end":93},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T71","span":{"begin":43,"end":45},"obj":"Chemical"},{"id":"T72","span":{"begin":114,"end":116},"obj":"Chemical"},{"id":"T73","span":{"begin":120,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A71","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A72","pred":"chebi_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/CHEBI_90326"},{"id":"A73","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-CHEBI

    {"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T48","span":{"begin":43,"end":45},"obj":"Chemical"},{"id":"T49","span":{"begin":120,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T58","span":{"begin":58,"end":68},"obj":"Species"},{"id":"T59","span":{"begin":131,"end":141},"obj":"Species"}],"attributes":[{"id":"A58","pred":"ncbi_taxonomy_id","subj":"T58","obj":"NCBItxid:2697049"},{"id":"A59","pred":"ncbi_taxonomy_id","subj":"T59","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T47","span":{"begin":17,"end":19},"obj":"Sentence"},{"id":"T48","span":{"begin":21,"end":77},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"242","span":{"begin":43,"end":49},"obj":"Gene"},{"id":"243","span":{"begin":58,"end":68},"obj":"Species"},{"id":"278","span":{"begin":152,"end":154},"obj":"Gene"},{"id":"290","span":{"begin":131,"end":141},"obj":"Species"},{"id":"295","span":{"begin":120,"end":122},"obj":"Chemical"},{"id":"309","span":{"begin":81,"end":87},"obj":"CellLine"}],"attributes":[{"id":"A243","pred":"pubann:denotes","subj":"243","obj":"Tax:2697049"},{"id":"A278","pred":"pubann:denotes","subj":"278","obj":"Gene:56925"},{"id":"A290","pred":"pubann:denotes","subj":"290","obj":"Tax:2697049"},{"id":"A295","pred":"pubann:denotes","subj":"295","obj":"MESH:D002738"},{"id":"A309","pred":"pubann:denotes","subj":"309","obj":"CVCL:0574"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T44","span":{"begin":21,"end":30},"obj":"http://purl.obolibrary.org/obo/IDO_0000559"},{"id":"T45","span":{"begin":88,"end":93},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T19","span":{"begin":88,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T44","span":{"begin":58,"end":68},"obj":"Disease"},{"id":"T45","span":{"begin":131,"end":141},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"242","span":{"begin":43,"end":49},"obj":"Gene"},{"id":"243","span":{"begin":58,"end":68},"obj":"Species"},{"id":"278","span":{"begin":152,"end":154},"obj":"Gene"},{"id":"290","span":{"begin":131,"end":141},"obj":"Species"},{"id":"295","span":{"begin":120,"end":122},"obj":"Chemical"},{"id":"309","span":{"begin":81,"end":87},"obj":"CellLine"}],"attributes":[{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:2697049"},{"id":"A278","pred":"tao:has_database_id","subj":"278","obj":"Gene:56925"},{"id":"A290","pred":"tao:has_database_id","subj":"290","obj":"Tax:2697049"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"MESH:D002738"},{"id":"A309","pred":"tao:has_database_id","subj":"309","obj":"CVCL:0574"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T47","span":{"begin":17,"end":19},"obj":"Sentence"},{"id":"T48","span":{"begin":21,"end":77},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ro and in vivo.\n\n3. Antiviral activity of CQ/HCQ against SARS-CoV-2 in vitro\nIn VeroE6 cells, the EC50, CC50 and SI of CQ against SARS-CoV-2 were 1.13 μM, \u003e100 and \u003e88.50, respective"}